Table 2 . Summary of the SNPs detected by the different approaches.
| BayeScan | Annotation | |||||||
|---|---|---|---|---|---|---|---|---|
| SNP | Clinality: R2 | MC sampling: no. SNPs affecting the SNP | Affected by | Log10(P.O.) | FST | Bayenv BF | AA change | Nucleotide |
| PaPHYN_RIII185 | 0.256 | 25 | 7 | −0.360 | 0.043 | 0.710 | ||
| PaPHYN_RIII88 | 0.510 | 0 | 12 | −0.427 | 0.051 | 4.276 | ||
| PaPHYO_RIII510 | 0.213 | 33 | 5 | −0.353 | 0.054 | 1.938 | ||
| PaPHYP_RIII274 | 0.404 | 0 | 14 | 2.743 | 0.139** | 25.175** | ||
| PaPHYP_RIII76 | 0.408 | 1 | 10 | −0.409 | 0.045 | 1.879 | ||
| PaMFTL1_1050 | 0.316 | 23 | 9 | 2.467 | 0.129** | 5.489* | ||
| PaMFTL1_2091 | 0.383 | 3 | 11 | 2.013 | 0.127** | 11.692** | ||
| PaMFTL1_2136 | — | — | — | 0.126 | 0.072 | 5.813* | ||
| PaMFTL1_2215 | 0.285 | 31 | 9 | −0.492 | 0.048 | 1.263 | ||
| PaMFTL1_3441 | 0.359 | 18 | 7 | 1.788 | 0.122** | 12.817** | ||
| PaMFTL1_3658 | 0.555 | 0 | 12 | 0.333 | 0.080 | 6.414* | ||
| PaMFTL1_802 | — | — | — | 1.469 | 0.127* | 6.540* | ||
| PaFTL2pr_1560 | 0.419 | 6 | 9 | −0.417 | 0.050 | 0.617 | ||
| PaFTL2pr_1824 | 0.493 | 0 | 15 | −0.347 | 0.053 | 3.300 | ||
| PaFTL2pr_1951 | 0.641 | 0 | 14 | 1.540 | 0.121** | 18.346** | ||
| PaFTL2pr_2173 | 0.459 | 6 | 13 | 0.850 | 0.101* | 5.254 * | ||
| PaFTL2pr_2509 | 0.441 | 2 | 13 | 1.915 | 0.133** | 16.667** | ||
| PaFTL2pr_2694 | 0.387 | 7 | 13 | 1.159 | 0.108* | 5.752* | ||
| PaFTL2pr_2790 | 0.396 | 11 | 12 | 1.284 | 0.112* | 4.963* | ||
| PaGI_F2_9_1470 | 0.543 | 0 | 7 | 0.596 | 0.090 | 2.752 | His to Tyr | CAT to TAT |
| PaGI_F2_9_987 | 0.479 | 1 | 8 | 1000 | 0.170** | 117.407** | His to Tyr | CAT to TAT |
| PaGI_F6_8_1111 | 0.244 | 1 | 6 | −0.061 | 0.036 | 0.627 | ||
| PaHB3_385 | 0.349 | 0 | 8 | −0.116 | 0.036 | 0.582 | ||
| PaKN2a_253 | 0.240 | 33 | 6 | −0.411 | 0.043 | 0.557 | ||
| PaKN2b_1157 | — | — | — | 0.702 | 0.020* | 0.592 | ||
| PaKN3a_211 | 0.377 | 0 | 12 | −0.521 | 0.045 | 0.873 | ||
| PaKN4b_242 | 0.251 | 33 | 8 | 0.415 | 0.088 | 47.522** | ||
| PaCCA1_1302 | 0.288 | 22 | 7 | −0.381 | 0.043 | 0.533 | ||
| PaPRR1_1992 | — | — | — | −0.529 | 0.047 | 4.884* | ||
| PaPRR1_2990 | — | — | — | −0.503 | 0.048 | 4.871* | ||
| PaPRR1_3301 | — | — | — | −0.511 | 0.048 | 4.721* | ||
| PaPRR3_F1_2570 | 0.380 | 0 | 7 | −0.319 | 0.055 | 3.244 | ||
| PaPRR3_F1_2978 | — | — | — | 1.722 | 0.123** | 2.568 | ||
| PaPRR3_F2_331 | 0.309 | 25 | 8 | −0.504 | 0.048 | 4.213 | ||
| PaPRR3_F2_481 | 0.354 | 1 | 8 | −0.369 | 0.055 | 3.009 | ||
| PaPRR7_F1_1505 | 0.455 | 0 | 11 | −0.237 | 0.060 | 2.965 | ||
| PaPRR7_F1_771 | 0.683 | 2 | 11 | 2.467 | 0.126** | 3.842 | ||
| PaPRR7_F2_417 | 0.230 | 33 | 7 | −0.374 | 0.053 | 1.768 | ||
| PaPRR7_F2_534 | 0.673 | 2 | 11 | 1000 | 0.138** | 4.458 | Ser to Thr | TCT to ACT |
| PaPRR7_F3_104 | 0.689 | 2 | 11 | 1000 | 0.161** | 9.906* | ||
| PaZTL_793 | 0.352 | 7 | 7 | −0.343 | 0.041 | 0.677 | ||
See the main text for details on the different approaches. *P < 0.05; **P < 0.01. Log10(P.O.) (P.O., posterior odds): 0.5–1, substantial evidence; 1–1.5, strong evidence; 1.5–2, very strong; >2, decisive evidence. Bayes factors: 3.2–10, substantial evidence; 10–100, strong evidence; >100, decisive evidence.